<DOC>
	<DOCNO>NCT01094145</DOCNO>
	<brief_summary>In study hand , six patient light moderate Alzheimer 's disease enrol implanted bilateral electrode nucleus basalis Meynert .</brief_summary>
	<brief_title>Deep Brain Stimulation ( DBS ) Nucleus Basalis Meynert ( NBM ) Treat Cognitive Deficits Light Moderate Alzheimer 's Disease</brief_title>
	<detailed_description>In study hand , six patient light moderate Alzheimer 's disease enrol implanted bilateral electrode nucleus basalis Meynert . The stereotactic implantation electrode guide computerized tomography ( CT ) magnetic resonance tomography ( MRT ) . Basically , even though deep brain stimulation invasive method , side effect . Surgical risk correspond risk DBS morbus Parkinson movement disorder ( 0,4-6 % ) . After baseline examination , patient implant electrode ; accordingly follow-up accomplish postoperative . From second week operation , conventional stimulation take place doubleblind , randomize change ON OFF period . Modifications stimulation parameter obtain best possible result possible . Throughout one-year observation-period , patient follow closely monitor effect DBS cognitive ability , psychopathological well , quality life , praxie nutritional condition use standardized neurological psychiatric rating scale .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>German speak male/female subject age:6080 AD assess DSMIV , ICD10 NINCDSADRDAScale LewyBodydementia form dementia MMST &gt; 18 &lt; 26 stable psychopharmacological medication psychotic symptom , suicidal tendency education least 8 year write informed consent patient consent least two family member contraindication regard PETexamination contraindication regard anesthesia stereotactic operation legal accommodation clinical comorbidity contraindication MRT examination psychotic symptom last six month aggressive behavior suicidal tendency verbal IQ &lt; 85 stereotactic operation previous history neoplastic neurological disease serious organic disease</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>( light moderate )</keyword>
</DOC>